First-trimester prediction of hypertensive disorders in pregnancy

Hypertension

Volumn 53, Issue 5, 2009, Pages 812-818

  Poon, Leona C Y ^a   Kametas, Nikos A ^a   Maiz, Nerea ^a   Akolekar, Ranjit ^a   Nicolaides, Kypros H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

First trimester screening; Mean arterial pressure; PAPP A; Placental growth factor; Preeclampsia; Uterine artery Doppler

Indexed keywords

PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ALGORITHM; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEAN ARTERIAL PRESSURE; PREDICTION; PREECLAMPSIA; PRENATAL CARE; PRIORITY JOURNAL; SCREENING;

ADULT; BODY MASS INDEX; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; LOGISTIC MODELS; MEMBRANE PROTEINS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 70349338116     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.127977     Document Type: Article

References (40)

1. World Health Organization. Make Every Mother and Child Count. World Health Report, 2005. Geneva, Switzerland: World Health Organization; 2005.
2. Lewis G, ed. The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers' Lives: Reviewing Maternal Deaths to Make Motherhood Safer-2003-2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London, United Kingdom: Confidential Enquiry into Maternal and Child Health; 2007.
3. Confidential Enquiry into Maternal and Child Health (CEMACH). Perinatal Mortality 2006: England, Wales and Northern Ireland. London, United Kingdom: Confidential Enquiry into Maternal and Child Health; 2008.
4. American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin: diagnosis and management of pre-eclampsia and eclampsia: number 33, January 2002. Obstet Gynecol. 2002; 99: 159-167.
5. National Collaborating Centre for Women's and Children's Health. Antenatal Care: Routine Care for the Healthy Pregnant Woman. Clinical Guideline. Commissioned by the National Institute for Clinical Excellence. London, United Kingdom: RCOG Press; 2008.
6. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005; 330: 565-572.
7. Yu CK, Smith GC, Papageorghiou AT, Cacho AM, Nicolaides KH. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol. 2005; 193: 429-436.
8. Poon LC, Kametas NA, Pandeva I, Valencia C, Nicolaides KH. Mean arterial pressure at 11(+0) to 13(+6) weeks in the prediction of preeclampsia. Hypertension. 2008; 51: 1027-1033.
9. 9. Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. Uterine artery Doppler at 11 +0 to 13+6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2007; 30: 742-749. (Pubitemid 47612696)
10. Poon LCY, Maiz N, Valencia C, Plasencia W, Nicolaides KH. Firsttrimester maternal serum PAPP-A and preeclampsia. Ultrasound Obstet Gynecol. 2008; 33: 23-33.
11. Akolekar R, Zaragoza E, Poon LCY, Pepes S, Nicolaides KH. Maternal serum placental growth factor (PlGF) at 11+0 to 13+6 weeks of gestation in the prediction of preeclampsia. Ultrasound Obstet Gynecol. 2008; 32: 732-739.
12. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet. 1998; 352: 343-346.
13. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. Screening for trisomy 21 by maternal age, fetal NT, free β hCG and PAPP-A. Ultrasound Obstet Gynecol. 2008; 31: 618-624.
14. 14. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988; 158: 892-898. (Pubitemid 18106884)
15. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH. Firsttrimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol. 2008; 31: 493-502.
16. Zaragoza E, Akolekar R, Poon LCY, Pepes S, Nicolaides KH. Maternal serum placental growth factor (PlGF) at 11+0-13+6 weeks in chromosomally abnormal pregnancies. Ultrasound Obstet Gynecol. 2009; 33: 382-386.
17. 17. Bindra R, Curcio P, Cicero S, Martin A, Nicolaides KH. Uterine artery Doppler at 11-14 weeks of gestation in chromosomally abnormal fetuses. Ultrasound Obstet Gynecol. 2001; 18: 587-589. (Pubitemid 34063055)
18. 18. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karamanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003; 111: 649-658. (Pubitemid 36278583)
19. 19. Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res. 2004; 95: 884-891. (Pubitemid 39435003)
20. 20. Stepan H, Unversucht A, Wessel N, Faber R. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension. 2007; 49: 818-824. (Pubitemid 351664216)
21. 21. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004; 350: 672-683. (Pubitemid 38364626)
22. 22. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates JR III, Conover CA. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sei U S A. 1999; 96: 3149-3153. (Pubitemid 29148859)
23. 23. Bonno M, Oxvig C, Kephart GM, Wagner JM, Kristensen T, SottrupJensen L, Gleich GJ. Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab Invest. 1994; 71: 560-566. (Pubitemid 24338164)
24. 24. Irwin JC, Suen LF, Martina NA, Mark SP, Giudice LC. Role of the IGF system in trophoblast invasion and pre-eclampsia. Hum Reprod. 1999; 14(suppl 2): 90-96. (Pubitemid 30040667)
25. von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy. 2003; 22: 143-148.
26. Witlin GA, Saade GR, Mattar FM, Sibai BM. Predictors of neonatal outcome in women with severe pre-eclampsia or eclampsia between 24 and 33 weeks' gestation. Am J Obstet Gynecol. 2000; 182: 607-611.
27. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ. 2001; 323: 1213-1217.
28. 28. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small-for-gestational age infants. BJOG. 1986; 93: 1049-1059. (Pubitemid 16004866)
29. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, van Assche A. Placental bed spiral arteries in the hypertensive disorders of pregnancy. BJOG. 1991; 98: 648-655.
30. 30. Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B. The frequency and severity of placental findings in women with pre-eclampsia are gestational age dependent. Am J Obstet Gynecol. 2003; 189: 1173-1177. (Pubitemid 37373917)
31. Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Morphometric placental villous and vascular abnormalities in early- and late-onset preeclampsia with and without fetal growth restriction. BJOG. 2006; 113: 580-589.
32. 32. D'Anna R, Baviera G, Corrado F, Giordano D, De Vivo A, Nicocia G, Di Benedetto A. Adiponectin and insulin resistance in early- and late-onset pre-eclampsia. BJOG. 2006; 113: 1264-1269. (Pubitemid 44581516)
33. Bosio PM, McKenna PJ, Conroy R, O'Herlihy C. Maternal central hemodynamics in hypertensive disorders or pregnancy. Obstet Gynecol. 1999; 94: 978-984.
34. Easterling TR, Benedetti TJ, Schmucker BC, Millard SP. Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol. 1990; 76: 1061-1069.
35. 35. Collis T, Devereux RB, Roman MJ, de Simone G, Yeh J, Howard BV, Fabsitz RR, Welty TK. Relations of stroke volume and cardiac output to body composition: the strong heart study. Circulation. 2001; 103: 820-825. (Pubitemid 32163879)
36. Messerli FH, Ventura HO, Reisin E, Dreslinski GR, Dunn FG, MacPhee AA, Frohlich ED. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation. 1982; 66: 55-60.
37. 37. Sharma AM. Mediastinal fat, insulin resistance, and hypertension. Hypertension. 2004; 44: 117-118. (Pubitemid 39014222)
38. Khaw A, Kametas NA, Turan OM, Bamfo JE, Nicolaides KH. Maternal cardiac function and uterine artery Doppler at 11-14 weeks in the prediction of pre-eclampsia in nulliparous women. BJOG. 2008; 115: 369-376.
39. 39. De Paco C, Kametas N, Rencoret G, Strobl I, Nicolaides KH. Maternal cardiac output between 11 and 13 weeks of gestation in the prediction of preeclampsia and small for gestational age. Obstet Gynecol. 2008; 111: 292-300. (Pubitemid 351653418)
40. Darzi A. A Framework for Action. London, United Kingdom: NHS London; 2007. Available at: http://www.healthcareforlondon.nhs.uk. Accessed September 20, 2008.